🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT05328856
Recruiting Not applicable

Effects of Vital Shower on Quality of Life, Immune Function, Cardiovascular Regulation and Well-being

NCT05328856 · tracked via the Priya Life Science Germany tracker
Phase
Not applicable
Started
2022-05-25
Last updated
2025-03-06

Condition(s) studied

General Population

Investigational drug(s) / intervention(s)

Hansgrohe prototype/shower head

Hansgrohe prototype/shower head: Start of the shower with warm comfort temperature and usual body cleansing. Then the Vital shower is carried out for a total of 3-5 minutes, followed optionally by another warm shower with 30 seconds or direct transition to a classic cold shower for 30- 60 seconds

Study summary

The aim of this exploratory randomized controlled clinical study is to evaluate the health-promoting effects of Kneipp hydrotherapy, in the form of the Vital Shower in a four-week daily application.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Female and male patients between 18 and 70 years of age Exclusion Criteria: * Bad general condition * Serious acute or chronic comorbidity * Pregnancy and breast feeding period/ in the next 6 months * Participation in a clinical trial within the last 3 months before enrollment * Simultaneous participation in another clinical trial * Raynaud's disease or cold agglutinin disease * Severe mental illness * Insufficiently treated dermatological diseases (e.g. neurodermatitis, psoriasis) * Non-compatible sanitary shower or bath devices

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus Berlin State of Berlin Recruiting

More Charite University, Berlin, Germany trials in Germany

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05328856 on ClinicalTrials.gov ↗ ← All trials in Germany